Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response of SYN006 HFA MDI in Asthma
NCT02162784Phase 2Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Feb 2013
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide + procaterol in asthma, sponsored by Intech Biopharm Corporation. Started Feb 2013; status: completed.
02
Drugs
budesonide + procaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02162784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162784.